News search

    E.g., 24/07/2024
    E.g., 24/07/2024
    Alberto Sanz, Gerente del CNIC; Dr. Jordi Camí, director de la Fundación Pasqual Maragall; Dr. Valentín Fuster, director general del CNIC, y Dr. Borja Ibáñez, Director de Investigación Clínica del CNIC.
    About the CNIC
    30 May 2017
    Two of the of the largest research cohorts in Spain join together to work on the prevention of atherosclerosis and Alzheimer’s

    Los resultados permitirán avanzar en el conocimiento de la interacción entre los diversos factores de riesgo de ambas enfermedades
    About the CNIC
    29 May 2017
    CNIC participates in Scientific Weekend

    More tan 40 institutions participated in the VII edition of the “Scientific Weekend”
    The Commissioner of Health and Food Safety of the European Commission, Vytenis Andriukaitis, during his visit at CNIC.
    About the CNIC
    3 May 2017
    Health and Food Safety Commissioner from the European Commission visits CNIC

    The Health and Food Safety Commissioner from the European Commission, Vytenis Andriukaitis, visited Carlos III National Centre of Cardiovascular Research (CNIC)
    About the CNIC
    30 Apr 2017
    Nature Medicine: An immune cell subtype plays an ‘unexpected’ role in protecting against atherosclerosis
    Noelia Alonso-González, Juan Antonio Quintana y Andrés Hidalgo.
    Research
    24 Apr 2017
    'Journal of Experimental Medicine': Cell “canibalism” educates our defenses

    CNIC scientists show that when macrophages ingest these expired cells they acquire protective properties
    Gonzalo Pizarro, David Sanz-Rosa, Borja Ibáñez, Jaime García-Prieto, Mónica Gómez, Rocío Villena, and Andrés Hidalgo.
    Research
    18 Apr 2017
    'Nature Communications': CNIC scientists discover how a decades-old drug reduces the size of a heart attack

    The beta-blocker metoprolol can limit cardiac damage in patients having a heart attack
    Ángel Álvarez Prado, Prof. Jesús Vázquez, Juan Antonio López del Olmo, Dra. Almudena Ramiro y Dra. Virginia G. de Yébenes
    Research
    22 Feb 2017
    'Blood': New Treatment Target Identified for Aggressive Lymphomas

    Every year 400000 people are diagnosed with lymphoma, and 200000 people die from the consequences of this blood cancer
    Sra. Dña Icíar Areilza Carvaja; Sr. D. Julián Carlos Gállego, Director ejecutivo de la secretaria técnica de presidencia la Caixa; Sr. D. Pablo Fernández-Olano Martínez-Cattaneo, Director de Rel.Institucionales, Endesa; Sr. D. Francisco de Bergia González, Director de Asuntos Públicos de Presidencia de Telefónica ; Sr. D. Fernando Gutiérrez Junquera, Adjunto al Presidente, BBVA; Sr. D. Carlos Martínez Echavarría, Patrono de la Fundación Ramón Areces; Sra. Dña. Rosa María Sanz García, directora general de Re
    About the CNIC
    10 Feb 2017
    The Kings of Spain visit the CNIC

    Dr. Valentín Fuster, General Director of CNIC and Luis de Carlos, President of the Board of Trustees of the Pro CNIC Foundation, explained to Their Majesties some of CNIC’s and Pro CNIC Foundation’s most important research projects
    Research
    10 Jan 2017
    Nature Medicine: Inhibition of a specific protein prevents and reverses aortic aneurysm in models of Marfan syndrome and similar diseases

    The findings, published in Nature Medicine, suggest a major potential for NOS2 inhibitors in the treatment of thoracic aortic aneurysa
    Research
    21 Dec 2016
    Second call for proposals to access the ReDIB Scientific and Technical Singular Infrastructures (STSI)

    ReDIB is composed of two nodes, located at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) in Madrid and the Centro de Investigación Cooperativa en Biomateriales (CIC biomaGUNE) in San Sebastián